120 related articles for article (PubMed ID: 23683422)
1. [Primary bone marrow CD8 cytotoxic T-cell lymphoma coexpressed CD20: a case report and literatures review].
Jin X; Zhi YQ; Yu Y; Zhang YZ; Zhang L
Zhonghua Xue Ye Xue Za Zhi; 2013 Mar; 34(3):229-32. PubMed ID: 23683422
[TBL] [Abstract][Full Text] [Related]
2. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
3. Subcutaneous panniculitis-like T-cell lymphoma with bone marrow involvement.
Brown NA; Ross CW; Gudjonsson JE; Wale D; Pawarode A; Maillard I; Hristov AC
Am J Clin Pathol; 2015 Feb; 143(2):265-73. PubMed ID: 25596253
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow involvement as initial presentation of CD8 cytotoxic peripheral T-cell lymphoma with CD20 coexpression and relatively indolent clinical course.
Zhang Y; Zhang L; Jin X; Zhao H; Hao X; Peker D; Wei S; Sokol L; Moscinski L
Leuk Lymphoma; 2013 May; 54(5):1113-6. PubMed ID: 23035635
[No Abstract] [Full Text] [Related]
5. Cytotoxic large T-cell lymphoma with fulminant clinical course, CD8+ and CD56- phenotype, and its relation to Epstein-Barr virus: a report of two cases.
Kagami Y; Sobue R; Ito N; Yatabe Y; Taji H; Suzuki R; Seto M; Ogura M; Suchi T; Morishima Y; Nakamura S
Int J Hematol; 1999 Aug; 70(2):105-11. PubMed ID: 10497849
[TBL] [Abstract][Full Text] [Related]
6. CD20-positive primary nasal peripheral T-cell lymphoma: An analysis of one case and review of the literature.
Li YL; Wang HP; Zhang C; Zhai ZM
Cytometry B Clin Cytom; 2020 Jul; 98(4):348-354. PubMed ID: 31682318
[TBL] [Abstract][Full Text] [Related]
7. Primary cutaneous peripheral T-cell lymphoma with aberrant coexpression of CD20: case report and review of the literature.
Balmer NN; Hughey L; Busam KJ; Reddy V; Andea AA
Am J Dermatopathol; 2009 Apr; 31(2):187-92. PubMed ID: 19318808
[TBL] [Abstract][Full Text] [Related]
8. Subcutaneous panniculitis-like T-cell lymphoma: a clinicopathologic, immunophenotypic, and molecular study of 22 Asian cases according to WHO-EORTC classification.
Kong YY; Dai B; Kong JC; Zhou XY; Lu HF; Shen L; Du X; Shi DR
Am J Surg Pathol; 2008 Oct; 32(10):1495-502. PubMed ID: 18708940
[TBL] [Abstract][Full Text] [Related]
9. T-cell lymphoma of CD3+CD4+CD56+granular lymphocytes with hemophagocytic syndrome.
Noguchi M; Kawano Y; Sato N; Oshimi K
Leuk Lymphoma; 1997 Jul; 26(3-4):349-58. PubMed ID: 9322898
[TBL] [Abstract][Full Text] [Related]
10. Primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma: A case report and significance of timely ancillary testing.
Kavishwar VS; Kirti C; Kush R; Sunita K; Pratiksha C
Indian J Pathol Microbiol; 2016; 59(1):131-2. PubMed ID: 26960663
[No Abstract] [Full Text] [Related]
11. CD20-Positive nodal natural killer/T-cell lymphoma with cutaneous involvement.
Tsai YC; Chen CK; Wu YH
J Cutan Pathol; 2015 Sep; 42(9):639-44. PubMed ID: 25924981
[TBL] [Abstract][Full Text] [Related]
12. [CD20-positive T cell lymphoma: clinicopathological features of five cases].
Shao SH; Wang Y; Dai XY; Xiao YJ; Guan JJ; Lin DL; Wang JG; Li YJ; Xing XM; Zhao P
Zhonghua Bing Li Xue Za Zhi; 2020 Oct; 49(10):1021-1026. PubMed ID: 32992416
[No Abstract] [Full Text] [Related]
13. Primary cardiac cytotoxic T-cell lymphoma presenting with neurological deficits: a case report.
Deepti AN; Noone ML; Mahadevan A; Naresh KN; Yasha TC; Satishchandra P; Muthane UB; Shankar SK
Cardiovasc Pathol; 2008; 17(5):334-8. PubMed ID: 18402804
[TBL] [Abstract][Full Text] [Related]
14. Primary Cutaneous Acral CD8
Hathuc VM; Hristov AC; Smith LB
Arch Pathol Lab Med; 2017 Nov; 141(11):1469-1475. PubMed ID: 29072952
[TBL] [Abstract][Full Text] [Related]
15. An unusual case report of indolent T-cell lymphoproliferative disorder with aberrant CD20 expression involving the gastrointestinal tract and bone marrow.
Wang X; Ng CS; Chen C; Yu G; Yin W
Diagn Pathol; 2018 Oct; 13(1):82. PubMed ID: 30342536
[TBL] [Abstract][Full Text] [Related]
16. CD8-positive peripheral T-cell lymphoma with aberrant expression of CD20 and concurrent in situ follicular lymphoma.
Sagasta A; Molina-Urra R; Martinez D; Gonzalez-Farre B; Marti E; Herranz MJ; Estrach T; Campo E; Colomo L
J Cutan Pathol; 2015 Jan; 42(1):66-72. PubMed ID: 25354337
[TBL] [Abstract][Full Text] [Related]
17. Activation of infiltrating cytotoxic T lymphocytes and lymphoma cell apoptotic rates in gastric MALT lymphomas. Differences between high-grade and low-grade cases.
Guidoboni M; Doglioni C; Laurino L; Boiocchi M; Dolcetti R
Am J Pathol; 1999 Sep; 155(3):823-9. PubMed ID: 10487840
[TBL] [Abstract][Full Text] [Related]
18. The role of cytotoxic skin-homing CD8+ lymphocytes in cutaneous cytotoxic T-cell lymphoma and pityriasis lichenoides.
Wenzel J; Gütgemann I; Distelmaier M; Uerlich M; Mikus S; Bieber T; Tüting T
J Am Acad Dermatol; 2005 Sep; 53(3):422-7. PubMed ID: 16112347
[TBL] [Abstract][Full Text] [Related]
19. Primary cutaneous CD8+ cytotoxic T-cell lymphoma involving the epidermis and subcutis in a young child.
Wang L; Gao T; Wang G
J Cutan Pathol; 2015 Apr; 42(4):271-5. PubMed ID: 25458991
[TBL] [Abstract][Full Text] [Related]
20. Cellular immunotherapy for follicular lymphoma using genetically modified CD20-specific CD8+ cytotoxic T lymphocytes.
Wang J; Press OW; Lindgren CG; Greenberg P; Riddell S; Qian X; Laugen C; Raubitschek A; Forman SJ; Jensen MC
Mol Ther; 2004 Apr; 9(4):577-86. PubMed ID: 15093188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
